GoodRx Holdings, Inc. (GDRX) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to GoodRx Second Quarter 2025 Conference Call and Webcast. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question and answer session. To ask the question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising, your hand is raised. To withdraw your question, please press star 1-1 again. I would now like to turn the conference over to Aubrey Reynolds. You may begin. Ladies and gentlemen, please stand by. Your conference call will begin momentarily. Please stand by. Ladies and gentlemen, thank you for your patience. Please stand by. Your conference call will begin shortly. Please stand by. Good morning, everyone. Sorry for the delay. Welcome to GoodRx's earnings conference call for the second quarter 2025. Joining me today are Wendy Barnes, our chief executive officer, and Chris Mingatis, our chief financial officer. Before we begin, I'd like to remind everyone that this call will contain forward-looking statements. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding management plans, strategies, goals and objectives, our market opportunity, our anticipated financial performance, underlying trends in our business and industry, including ongoing changes in the pharmacy ecosystem, our value proposition, our long-term growth prospects, our direct and hybrid contracting approach, collaborations and partnerships with third parties, including our consumer direct price points and our integrated savings program, our e-commerce strategy, and our capital allocation priorities. These statements are neither pro...